Skip to main content

Table 2 Outcome for patients treated with Rifampicin for the full length of treatment (n = 321/411)

From: Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

  Total Low-dose Intermediate-dose High-dose
Recovery, n (%) 237 (73.8) 10 (55.5) 189 (76.2) 38 (69)
Treatment failure, n (%) 52 (16.2) 5 (27.8) 35 (14.1) 12 (21.8)
Lost to follow-up, n (%) 32 (10) 3 (16.7) 24 (9.7) 5 (9.1)
\